Innovations that could improve early recognition of ventilator-associated pneumonia

Intensive Care Medicine

Volumn 40, Issue 9, 2014, Pages 1352-1354

  Bos, Lieuwe D J ^a,b,c   Martin Loeches, Ignacio ^b,c   Artigas, Antonio ^b,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b HOSPITAL DE SABADELL   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BREATH ANALYSIS; COLORIMETRY; ENDOTRACHEAL TUBE; HUMAN; LUNG INFECTION; SHORT SURVEY; VENTILATOR ASSOCIATED PNEUMONIA; EARLY DIAGNOSIS; INVENTION; MICROBIOLOGY; PNEUMONIA, VENTILATOR-ASSOCIATED;

EARLY DIAGNOSIS; HUMANS; INVENTIONS; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 84906936711     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-014-3356-y     Document Type: Short Survey

References (14)

1. Fàbregas N, Ewig S, Torres A, El-Ebiary M, Ramirez J, de la Bellacasa JP, Bauer T, Cabello H (1999) Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate postmortem lung biopsies. Thorax 54:867-873 (Pubitemid 29452793)
2. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH (2002) Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122:262-268 (Pubitemid 34754172)
3. Gil-Perotin S, Ramirez P, Marti V, Sahuquillo J, Gonzalez E, Calleja I, Menendez R, Bonastre J (2012) Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept. Crit Care 16:R93
4. Millo JL, Schultz MJ, Williams C, Weverling GJ, Ringrose T, Mackinlay CI, van der Poll T, Garrard CS (2004) Compartmentalisation of cytokines and cytokine inhibitors in ventilatorassociated pneumonia. Intensive Care Med 30:68-74 (Pubitemid 38147109)
5. Jiang T, Liu R, Huang X, Feng H, Teo W, Xing B (2009) Colorimetric screening of bacterial enzyme activity and inhibition based on the aggregation of gold nanoparticles. Chem Commun 1972-1974
6. Rakow NA, Suslick KS (2000) A colorimetric sensor array for odour visualization. Nature 406:710-713
7. Carey JR, Suslick KS, Hulkower KI, Imlay JA, Imlay KRC, Ingison CK, Ponder JB, Sen A, Wittrig AE (2011) Rapid identification of bacteria with a disposable colorimetric sensing array. J Am Chem Soc 133:7571-7576
8. Schultz MJ, Millo J, Levi M, Hack CE, Weverling GJ, Garrard CS, van der Poll T (2004) Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 59:130-135 (Pubitemid 38223484)
9. Conway Morris A, Kefala K, Wilkinson TS, Moncayo-Nieto OL, Dhaliwal K, Farrell L, Walsh TS, Mackenzie SJ, Swann DG, Andrews PJ, Anderson N, Govan JR, Laurenson IF, Reid H, Davidson DJ, Haslett C, Sallenave JM, Simpson AJ (2010) Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax 65:201-207
10. Wilkinson TS, Conway Morris A, Kefala K, O'Kane CM, Moore NR, Booth NA, McAuley DF, Dhaliwal K, Walsh TS, Haslett C, Sallenave J-M, Simpson AJ (2012) Ventilatorassociated pneumonia is characterized by excessive release of neutrophil proteases in the lung. Chest J 142:1425-1432
11. Bos LDJ, Sterk PJ, Schultz MJ (2013) Volatile metabolites of pathogens: a systematic review. PLoS Pathog 9:e1003311
12. Bos LDJ, van Walree IC, Kolk AHJ, Janssen H-G, Sterk PJ, Schultz MJ (2013) Alterations of exhaled breath metabolite-mixtures in two rat models of lipopolysaccharide-induced lung injury. J Appl Physiol 115:1487-1495
13. Hanson CW III, Thaler ER (2005) Electronic nose prediction of a clinical pneumonia score: biosensors and microbes. Anesthesiology 102:63-68
14. Bos LDJ, Martin-Loeches I, Kastelijn JB, Gili G, Espasa M, Povoa P, Kolk AHJ, Janssen H-G, Sterk PJ, Artigas A, Schultz MJ (2014) The volatile metabolic fingerprint of ventilator-associated pneumonia. Intensive Care Medicine 40:761-762